<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cerebral blood flow has been measured using the non-invasive Xenon133 clearance technique in eight <z:mpath ids='MPATH_458'>normal</z:mpath> subjects during an infusion of epoprostenol (prostacyclin, <z:chebi fb="0" ids="15552">PGI2</z:chebi>) at a dose of 5 ng/kg/min </plain></SENT>
<SENT sid="1" pm="."><plain>The results were compared with a control infusion of saline given in a balanced order </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="15552">PGI2</z:chebi> was found to result in a reduction in cerebral blood flow of about 8% </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="15552">PGI2</z:chebi> also caused a small drop in diastolic blood pressure and it is proposed that the fall in cerebral blood flow may have been the result of disturbed autoregulation </plain></SENT>
<SENT sid="4" pm="."><plain>The findings suggest that the therapeutic use of <z:chebi fb="0" ids="15552">PGI2</z:chebi> in patients with <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral artery spasm</z:e> would not be accompanied by undesirable intracerebral steal </plain></SENT>
</text></document>